A University of Cincinnati study found administering an immunotherapy drug before surgery for oral cavity cancer did not lead to increased rates of complications during and after surgery.
This article was originally published on MedicalXpress.com
Pembrolizumab administration shown to not increase oral cavity surgery complications
You may also be interested in:
The Latest
How metacognition — thinking about thinking — can improve the mental-health crisis
In these times of virtual meet-ups, negative news overload and widespread uncertainty, it’s fair to say it has been a tough time for our brains. If you’ve been feeling mentally subpar, you may be floating […]
The Latest
Lyme carditis: Things can get complicated when Lyme disease affects heart function
Lyme disease is a tick-born infection caused by bacteria known as Borrelia burgdorferi. Lyme carditis is an early manifestation of Lyme disease that can occur two to six weeks after the tick bite. Approximately five to 10 per […]
The Latest
Canadians want home care, not long-term care facilities, after COVID-19
The COVID-19 pandemic has shed light on the precarious living conditions of the elderly in nursing homes in Canada. During the first wave of the pandemic, from March to August 2020, more than 80 per […]
Read More:
-
Researchers are joining forces with the food and health industries to tighten controls and improve nutrition for infants and children.This article was originally published on [...]
-
Toddlers whose moms were exposed to higher levels of air pollution during mid- to late-pregnancy tend to score lower on measures of cognition, motor coordination [...]
-
When visiting friends or family who have both houseplants and young children, I’ve been compared to “Aunt Bonnie” from the Geico commercial “Aunt Infestation.”This article [...]
